Go to the list of all blogs
Harry Richardson's Avatar
published in Blogs
Oct 09, 2023

$PGR, $CB, $TRV, $ALL, $EG, $WRB, $L have been growing by 2-5% in the past month, against the market trend.

 

Property/Casualty Insurance companies are outperforming the market, showing growth ranging from 2% to 5%. You can receive signals for these companies' stocks by subscribing to our trading robots AI Robots.

Market Cap The average market capitalization across the group is 40.6B. The market cap for tickers in the group ranges from 14.3B to 86.1B. CB holds the highest valuation in this group at 86.1B. The lowest valued company is L at 14.3B.

High and low price notable news The average weekly price growth across all stocks in the group was 1.52%. For the same group, the average monthly price growth was 4.57%, and the average quarterly price growth was 3.47%. EG experienced the highest price growth at 5.41%, while TRV experienced the biggest fall at -0.22%.

Fundamental Analysis Ratings The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67 P/E Growth Rating: 44 Price Growth Rating: 39 SMR Rating: 96 Profit Risk Rating: 23 Seasonality Score: 16 (-100 ... +100)

PGR in +0.49% Uptrend, growing for three consecutive days on October 06, 2023 Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PGR advanced for three days, in 194 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

Stock Forecast, Price, News, Quote Current price $142.93 is above $141.38 the highest resistance line found by A.I. Throughout the month of 09/06/23 - 10/06/23, the price experienced a +6% Uptrend. During the week of 09/29/23 - 10/06/23, the stock enjoyed a +3% Uptrend growth.

CB sees its 50-day moving average cross bullishly above its 200-day moving average The 50-day Moving Average for CB moved above the 200-day moving average on September 22, 2023. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Stock Forecast, Price, News, Quote Current price $209.49 crossed the support line at $205.88 and is trading between $218.31 resistance and $205.88 support lines. Throughout the month of 09/06/23 - 10/06/23, the price experienced a +4% Uptrend. During the week of 09/29/23 - 10/06/23, the stock enjoyed a +0.66% Uptrend growth.

TRV in downward trend: price dove below 50-day moving average on September 29, 2023 TRV moved below its 50-day Moving Average on September 29, 2023, indicating a change from an upward trend to a downward trend. In 30 of 48 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 62%.

Stock Forecast, Price, News, Quote Current price $162.97 crossed the resistance line at $188.23 and is trading between $188.23 resistance and $141.71 support lines. Throughout the month of 09/06/23 - 10/06/23, the price experienced a +2% Uptrend, while the week of 09/29/23 - 10/06/23 shows a -0.22% Downtrend.

ALL sees its Stochastic Oscillator ascending out of oversold territory On October 05, 2023, the Stochastic Indicator for ALL moved out of oversold territory. This could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 55 instances where the indicator left the oversold zone. In 36 of the 55 cases, the stock moved higher in the following days. This puts the odds of a move higher at over 65%.

Stock Forecast, Price, News, Quote Current price $113.10 is below $115.87 the lowest support line found by A.I. Throughout the month of 09/06/23 - 10/06/23, the price experienced a +5% Uptrend. During the week of 09/29/23 - 10/06/23, the stock enjoyed a +2% Uptrend growth.

EG sees its 50-day moving average cross bullishly above its 200-day moving average The 50-day Moving Average for EG moved above the 200-day moving average on September 07, 2023. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Stock Forecast, Price, News, Quote Current price $391.81 crossed the resistance line at $376.81 and is trading between $477.61 resistance and $376.81 resistance lines. Throughout the month of 09/06/23 - 10/06/23, the price experienced a +7% Uptrend. During the week of 09/29/23 - 10/06/23, the stock enjoyed a +5% Uptrend growth.

WRB in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 03, 2023 WRB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 25 of 34 cases where WRB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 74%.

Stock Forecast, Price, News, Quote Current price $63.90 is below $72.05 the lowest support line found by A.I. Throughout the month of 09/06/23 - 10/06/23, the price experienced a +5% Uptrend. During the week of 09/29/23 - 10/06/23, the stock enjoyed a +0.66% Uptrend growth.  

L in upward trend: price is expected to rise as it breaks its lower Bollinger Band on October 02, 2023. L may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 24 of 37 cases where L's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 65%.

Stock Forecast, Price, News, Quote Current price $63.27 crossed the support line at $58.48 and is trading between $74.50 resistance and $58.48 support lines. Throughout the month of 09/06/23 - 10/06/23, the price experienced a +3% Uptrend, while the week of 09/29/23 - 10/06/23 shows a -0.06% Downtrend.

Related Ticker: PGR, CB, TRV, ALL, EG, WRB, L

Contributor

Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.


PGR's Stochastic Oscillator is staying in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for PGR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The 10-day moving average for PGR crossed bullishly above the 50-day moving average on August 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 47%.

Following a +1.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where PGR advanced for three days, in 193 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

PGR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 184 of 323 cases where PGR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PGR as a result. In 43 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 45%.

The Moving Average Convergence Divergence Histogram (MACD) for PGR turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 26 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 54%.

PGR moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PGR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 33 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 56, placing this stock better than average.

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PGR's P/B Ratio (3.498) is slightly higher than the industry average of (2.049). P/E Ratio (10.383) is within average values for comparable stocks, (15.009). PGR's Projected Growth (PEG Ratio) (63.459) is very high in comparison to the industry average of (3.286). PGR's Dividend Yield (0.067) is considerably higher than the industry average of (0.018). P/S Ratio (1.400) is also within normal values, averaging (1.594).

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. PGR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 70 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Industry description

Property and casualty companies insure against accidents of non-physical harm, such as lawsuits, damage to personal assets, car crashes and more. Progressive Corporation, Travelers Companies, Inc. and Allstate Corporation are some of the biggest providers of such products.

Market Cap

The average market capitalization across the Property/Casualty Insurance Industry is 13.01B. The market cap for tickers in the group ranges from 0 to 129.54B. CB holds the highest valuation in this group at 129.54B. The lowest valued company is FXFLF at 0.

High and low price notable news

The average weekly price growth across all stocks in the Property/Casualty Insurance Industry was -5%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was 19%. PRHI experienced the highest price growth at 6%, while GBLI experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Property/Casualty Insurance Industry was 17%. For the same stocks of the Industry, the average monthly volume growth was 47% and the average quarterly volume growth was 24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 63
Price Growth Rating: 51
SMR Rating: 69
Profit Risk Rating: 56
Seasonality Score: -9 (-100 ... +100)
View a ticker or compare two or three
PGR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of automobile and casualty insurance services

Industry PropertyCasualtyInsurance

Industry
Property Or Casualty Insurance
Address
300 North Commons Boulevard
Phone
+1 440 461-5000
Employees
70053
Web
https://www.progressive.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.